Derek Skinner

640 total citations
35 papers, 389 citations indexed

About

Derek Skinner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Derek Skinner has authored 35 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Derek Skinner's work include Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (9 papers). Derek Skinner is often cited by papers focused on Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (9 papers). Derek Skinner collaborates with scholars based in United Kingdom, Singapore and France. Derek Skinner's co-authors include David Price, Victoria Carter, Victoria Thomas, Jessica Martin, David Halpin, John Haughney, Brian J. Lipworth, Graham Devereux, Hilda J.I. de Jong and Andrew Menzies‐Gow and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Respiratory Journal.

In The Last Decade

Derek Skinner

34 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek Skinner United Kingdom 10 269 236 48 24 24 35 389
Alicia Guillien France 12 211 0.8× 78 0.3× 44 0.9× 22 0.9× 21 0.9× 42 364
L. Ramage United Kingdom 7 267 1.0× 283 1.2× 14 0.3× 14 0.6× 31 1.3× 10 383
Howraman Meteran Denmark 13 206 0.8× 207 0.9× 10 0.2× 23 1.0× 49 2.0× 40 379
Cynthia W. Baffi United States 5 146 0.5× 165 0.7× 25 0.5× 10 0.4× 8 0.3× 5 298
И. В. Демко Russia 7 198 0.7× 142 0.6× 24 0.5× 10 0.4× 18 0.8× 98 372
Ariadna Petronela Fildan Romania 9 153 0.6× 65 0.3× 19 0.4× 27 1.1× 5 0.2× 28 260
Ovcharenko Si Russia 8 271 1.0× 137 0.6× 42 0.9× 10 0.4× 6 0.3× 58 326
G. Balzano Italy 8 290 1.1× 229 1.0× 13 0.3× 9 0.4× 40 1.7× 16 458
Rebeca Baz Spain 5 316 1.2× 140 0.6× 34 0.7× 4 0.2× 5 0.2× 8 369
Minna Tommola Finland 7 225 0.8× 237 1.0× 6 0.1× 11 0.5× 23 1.0× 14 297

Countries citing papers authored by Derek Skinner

Since Specialization
Citations

This map shows the geographic impact of Derek Skinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Skinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Skinner more than expected).

Fields of papers citing papers by Derek Skinner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Skinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Skinner. The network helps show where Derek Skinner may publish in the future.

Co-authorship network of co-authors of Derek Skinner

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Skinner. A scholar is included among the top collaborators of Derek Skinner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Skinner. Derek Skinner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Trung N., Jennifer Rowell, Jeffrey Shi Kai Chan, et al.. (2024). Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom. SHILAP Revista de lepidopterología. 3(2). 100225–100225. 1 indexed citations
2.
3.
Tse, Gary, Cono Ariti, Mona Bafadhel, et al.. (2024). Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD. Advances in Therapy. 42(1). 375–394. 1 indexed citations
4.
Halpin, David, et al.. (2024). Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations. European Respiratory Journal. 64(4). 2302240–2302240. 7 indexed citations
5.
Tse, Gary, Benjamin Emmanuel, Cono Ariti, et al.. (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. International Journal of COPD. Volume 18. 2565–2580. 12 indexed citations
6.
Haughney, John, Trung N. Tran, Arnaud Bourdin, et al.. (2023). Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma. npj Primary Care Respiratory Medicine. 33(1). 9–9. 2 indexed citations
7.
Price, David, William Henley, José Eduardo Delfini Cançado, et al.. (2022). Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone. SHILAP Revista de lepidopterología. 6 indexed citations
8.
Pavord, Ian, Trung N. Tran, Rupert Jones, et al.. (2022). Effect of Stepping Up to High-Dose Inhaled Corticosteroids in Patients With Asthma: UK Database Study. The Journal of Allergy and Clinical Immunology In Practice. 11(2). 532–543. 8 indexed citations
9.
Soremekun, Seyi, Liam G. Heaney, Derek Skinner, et al.. (2022). Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study. Thorax. 78(7). 643–652. 54 indexed citations
10.
Soremekun, Seyi, Liam G. Heaney, Jaco Voorham, et al.. (2020). The Impact of Exacerbation Burden on Lung Function Trajectory in a Broad UK Asthma Population: A Large Longitudinal Cohort Study. A6248–A6248. 2 indexed citations
11.
Halpin, David, Hilda J.I. de Jong, Victoria Carter, Derek Skinner, & David Price. (2019). Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019. EClinicalMedicine. 14. 32–41. 40 indexed citations
12.
13.
14.
Carney, A. Simon, David Price, Peter Smith, et al.. (2017). Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study. PubMed. Volume 8. 157–165. 2 indexed citations
15.
Haughney, John, Iain Small, Stephanie Wolfe, et al.. (2017). Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation. Respiratory Medicine. 129. 199–206. 9 indexed citations
16.
Jones, Rupert, Jessica Martin, Victoria Thomas, et al.. (2017). The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study. International Journal of COPD. Volume 12. 2445–2454. 16 indexed citations
17.
Price, David, Richard Russell, Rafael Marés, et al.. (2016). Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study. PLoS ONE. 11(9). e0162903–e0162903. 62 indexed citations
18.
Belhassen, Manon, Anjan Nibber, Éric Van Ganse, et al.. (2016). Inappropriate asthma therapy—a tale of two countries: a parallel population-based cohort study. npj Primary Care Respiratory Medicine. 26(1). 16076–16076. 28 indexed citations
19.
Lipworth, Brian J., Derek Skinner, Graham Devereux, et al.. (2016). Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease. Heart. 102(23). 1909–1914. 58 indexed citations
20.
Bailey, Donald B., et al.. (2001). Delayed Diagnosis of Fragile X Syndrome --- United States, 1990--1999. MMWR Morbidity and Mortality Weekly Report. 51(33). 740–742. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicia Guillien Breakdown of academic impact, for papers by L. Ramage Breakdown of academic impact, for papers by Howraman Meteran Breakdown of academic impact, for papers by Cynthia W. Baffi Breakdown of academic impact, for papers by И. В. Демко Breakdown of academic impact, for papers by Ariadna Petronela Fildan Breakdown of academic impact, for papers by Ovcharenko Si Breakdown of academic impact, for papers by G. Balzano Breakdown of academic impact, for papers by Rebeca Baz Breakdown of academic impact, for papers by Minna Tommola
Rankless by CCL
2026